HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 901-912 of 1,811
Drug study icon
CompletedNCT03375021

CX717 in the Treatment of Adult ADHD

Official study title

A Randomized, Double-Blind, Tw0-Period Crossover Study to Assess the Efficacy and Safety of the Ampakine® Compound, CX717, Versus Placebo in Adults With Attention-Deficit Hyperactive Disorder

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDMedication studyAges 18–50
Countries
Sponsor
RespireRx
Drug study icon
CompletedNCT02195167

Dasotraline SEP360-105 Pediatric PK/PD Study

Official study title

A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
ADHDMedication studyAges 6–17
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Behavioral study icon
CompletedNCT05435651

Digital Therapy for Treating Attention Deficit Hyperactivity Disorder

Official study title

A Randomized Clinical Trial to Assess The Effectiveness and Safety of Digital Therapy for Treating Attention Deficit Hyperactivity Disorder in Children

This study has finished and is no longer accepting participants.

In Shanghai
ADHDBehavioural studyAges 6–12
Countries
China
Sponsor
Children's Hospital of Fudan University
Drug study icon
CompletedNCT00500071

Safety study of vyvanse (Lisdexamfetamine Dimesylate) in ADHD

What is this study about?

Researchers studied Vyvanse (lisdexamfetamine dimesylate) to find out how it affected ADHD symptoms in children with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Scottsdale
ADHDMedication studyAges 6–12
Countries
United States
Sponsor
Shire
Device study icon
CompletedNCT02251743

2-Site study of Neurofeedback for ADHD

Official study title

Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD

This study has finished and is no longer accepting participants.

Multiple locations, including Asheville
ADHDDevice studyAges 7–10
Countries
United States
Sponsor
Ohio State University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.